Position in TMO
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$13,035
+$1,239 QoQ
Shares Held
26
+8.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#2,517
of 2,602 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Tidemark, LLC holds $110,967 across 11 Diagnostics & Research names. TMO ranks #3 (11.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ILMN |
Illumina, Inc.
|
325 | $57,144 | |
| 2 | DHR |
Danaher Corp /De/
|
88 | $16,762 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
This page
|
26 | $13,035 | |
| 4 | GH |
Guardant Health, Inc.
|
50 | $7,501 | |
| 5 | CRL |
Charles River Laboratories International, Inc.
|
26 | $5,896 | |
| 6 | WAT |
Waters Corp /De/
|
14 | $5,250 | |
| 7 | LH |
Labcorp Holdings Inc.
|
12 | $3,360 | |
| 8 | GRAL |
GRAIL, Inc.
|
12 | $819 |
All Filings in TMO
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,035 | 26 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $11,796 | 24 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $11,009 | 19 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $10,670 | 22 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $8,920 | 22 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $9,454 | 19 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $4,682 | 9 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $5,567 | 9 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $4,977 | 9 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $5,230 | 9 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $4,777 | 9 | Shares | Sole | 2024-02-09 | |
| No filing history on record for this holder in this stock. | ||||||